NYMC Faculty Publications
Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis
Author Type(s)
Faculty
DOI
10.1093/cid/ciaa1216
Journal Title
Clinical Infectious Diseases
First Page
49
Last Page
64
Document Type
Article
Publication Date
1-27-2021
Department
Medicine
Abstract
The purpose of this guideline is to provide evidence-based guidance for the most effective strategies for the diagnosis and management of babesiosis. The diagnosis and treatment of co-infection with babesiosis and Lyme disease will be addressed in a separate Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR) guideline [1]. Recommendations for the diagnosis and treatment of human granulocytic anaplasmosis can be found in the recent rickettsial disease guideline developed by the Centers for Disease Control and Prevention [2]. The target audience for the babesiosis guideline includes primary care physicians and specialists caring for this condition, such as infectious diseases specialists, emergency physicians, intensivists, internists, pediatricians, hematologists, and transfusion medicine specialists.
Recommended Citation
Krause, P. J., Auwaerter, P. G., Bannuru, R. R., Branda, J. A., Falck-Ytter, Y. T., Lantos, P. M., Lavergne, V., Meissner, H. C., Osani, M. C., Rips, J., Sood, S. K., Vannier, E., Vaysbrot, E. E., & Wormser, G. P. (2021). Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis. Clinical Infectious Diseases, 72 (2), 49-64. https://doi.org/10.1093/cid/ciaa1216